17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Stay at home orders. Social distancing measures. We talked with Mark Bloom and Andrew Ross about the...
Read More >
What were the five biggest employment law developments in 2019? From new laws to big decisions, we t...
Read More >
Following Corwin v. KKR Financial Holdings and other Delaware cases that have reinforced the standar...
Read More >
A construction project can be a breeding ground for general contractor versus subcontractor payment ...
Read More >
The coronavirus outbreak which was first alerted to the World Health Organisation (WHO) by Chinese a...
Read More >
The Background: The U.S. Securities and Exchange Commission ("the SEC") has announced that it may no...
Read More >